Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -87.92x is 737% below its 5-year average of 13.81x, near the low end of its 5-year range (-190.92x–428.58x).
154.08% below its 12-month average of -34.60x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -183.66x.
INTEREST COVERAGE RATIO
-87.92x
INTEREST COVERAGE RATIO AVG TTM
-34.60x
INTEREST COVERAGE RATIO AVG 3Y
-13.68x
INTEREST COVERAGE RATIO AVG 5Y
13.81x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-154.08%
CURRENT VS 3Y AVG
-542.68%
CURRENT VS 5Y AVG
-736.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-1279.14%
vs the sector median at left
DocGo Inc.
Market Cap
$35.29M
Interest Coverage Ratio
-87.92x
TTM Avg
-34.60x
3Y Avg
-13.68x
5Y Avg
13.81x
Market Cap
$35.46M
Interest Coverage Ratio
-33.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.06M
Interest Coverage Ratio
-735.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.49M
Interest Coverage Ratio
47.58x
TTM Avg
47.58x
3Y Avg
47.58x
5Y Avg
47.58x
Market Cap
$36.17M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.26M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.42M
Interest Coverage Ratio
-1.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.70M
Interest Coverage Ratio
-10.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.63M
Interest Coverage Ratio
-23.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DocGo Inc. (DCGO) | $35.29M | -87.92x | -34.60x | -13.68x | 13.81x |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.46M | -33.29x | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | -735.69x | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.49M | 47.58x | 47.58x | 47.58x | 47.58x |
| Edesa Biotech, Inc. (EDSA)vs › | $36.17M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.26M | N/A | N/A | N/A | N/A |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.42M | -1.68x | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $36.70M | -10.67x | N/A | N/A | N/A |
| Scilex Holding Company (SCLX)vs › | $33.63M | -23.76x | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $32.95M | N/A | 8.27x | 8.27x | 8.27x |
Interest Coverage
-87.9x
Debt/Equity
0.22
Current Ratio
1.66
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -183.66x |
| 2026-03-31 | -187.61x |
| 2025-12-31 | 428.58x |
| 2025-09-30 | -190.92x |
| 2025-06-30 | -39.40x |
| 2025-03-31 | -32.84x |
| 2024-12-31 | -13.80x |
| 2024-09-30 | 20.07x |
| 2024-06-30 | 19.76x |
| 2024-03-31 | 43.02x |
| 2022-03-31 | 74.44x |
| 2021-12-31 | 58.94x |
| 2021-09-30 | 5.94x |
| 2021-06-30 | 1.99x |
| 2021-03-31 | -16.29x |
| 2020-06-30 | -93.52x |
